---
title: "韩国宣传的“干细胞丰胸”（SVF）和普通自体脂肪丰胸有什么区别？可信吗？"
url: "https://worldwiki.io/zh-CN/q/韩国宣传的-干细胞丰胸-svf-和普通自体脂肪丰胸有什么区别-可信吗"
type: "question"
language: "zh"
intent: "comparison"
entity: "Breast Fat Grafting"
topic: "Breast Augmentation"
published: "2026-09-20 08:11:10"
updated: "2026-09-21 09:03:04"
---

# 韩国宣传的“干细胞丰胸”（SVF）和普通自体脂肪丰胸有什么区别？可信吗？

## 简短回答

从监管角度看两者并不相同：按美国FDA 2017年11月发布的指南，自体脂肪移植不需要上市前批准，而基质血管组分（SVF）类产品会受到更严格的审查；FDA另有面向消费者的干细胞疗法风险提醒。本条目引用的两项SVF隆胸研究由医疗机构关联作者发表，属于提供方关联证据，不能视作独立验证。韩国与中国对这类细胞操作如何归类，不在本条目来源范围内，须向机构索取书面说明。

## 回答

**概念上的差别**：普通自体脂肪丰胸是取出脂肪、处理后回注；SVF方案则涉及对脂肪进行进一步处理以获得基质血管组分再一起注射。

**监管上的差别（美国口径）**：在FDA于2017年11月发布指南后，**自体脂肪移植不需要上市前批准，而SVF类产品会受到更严格的审查**。[1]相关指南为《21 CFR 1271.15(b) 同一手术例外：关于例外范围的问答》，该例外适用于在同一次手术中取出并回植的组织。[2]FDA还发布过面向消费者的干细胞疗法风险提醒。[8]

**证据的独立性**：本条目收录的两项SVF隆胸研究由医疗机构关联作者发表[3][7]，属于提供方关联证据；关于细胞辅助脂肪移植（CAL）与PRP辅助脂肪移植的系统综述则为独立文献[4][5]，另有一篇关于自体SVF临床使用安全性的文献综述[6]。查阅时应区分谁做的研究。

**需要如实说明的是**：韩国和中国对SVF、干细胞类操作的具体法规归类**不在本条目所引用的来源中**。若医疗机构宣传“干细胞丰胸”，应要求对方以书面形式说明：注射的究竟是什么（未培养的SVF、PRP还是培养扩增的细胞）、在哪个许可设施内处理、适用哪部法规和哪个批准编号，并索取可核查的文件。

## 已验证服务机构

- [SC301의원](https://worldwiki.io/zh-CN/entity/sc301) — SC301의원 (SC301 Clinic) is a plastic surgery clinic in Gangnam, Seoul, South Korea whose official site presents SVF (stromal vascular fraction) fat grafting for the breast and face, liposuction, liftin

## 相关问题

- [자가지방 가슴성형은 어떻게 진행되나?](https://worldwiki.io/ko/q/자가지방-가슴성형은-어떻게-진행되나)
- [자연 가슴성형, 무보형물 가슴성형 방법에는 무엇이 있고 누구에게 적합한가요?](https://worldwiki.io/ko/q/자연-가슴성형-무보형물-가슴성형-방법에는-무엇이-있고-누구에게-적합한가요)
- [가슴 지방이식 후 크기는 언제쯤 자리 잡나요?](https://worldwiki.io/ko/q/가슴-지방이식-후-크기는-언제쯤-자리-잡나요)
- [How much bigger can breasts get with fat transfer?](https://worldwiki.io/q/how-much-bigger-can-breasts-get-with-fat-transfer)
- [脂肪注入豊胸の定着率（生着率）は実際どれくらいですか？クリニックが出す数字と違いますか？](https://worldwiki.io/ja/q/脂肪注入豊胸の定着率-生着率-は実際どれくらいですか-クリニックが出す数字と違いますか)
- [한 번에 300cc 이상 넣는 대용량 가슴 지방이식은 가능한가요? 조건과 위험은 무엇인가요?](https://worldwiki.io/ko/q/한-번에-300cc-이상-넣는-대용량-가슴-지방이식은-가능한가요-조건과-위험은-무엇인가요)

## 来源

1. [Safety and Regulation of Fat Grafting (Raj S, Abu-Ghname A, Davis MJ, Izaddoost SA, Winocour SJ; Semin Plast Surg 2020;34(1):59–64)](https://pmc.ncbi.nlm.nih.gov/articles/PMC7023970/) — Seminars in Plastic Surgery (Thieme) via PubMed Central · evidence page: https://worldwiki.io/source/274
2. [Same Surgical Procedure Exception under 21 CFR 1271.15(b): Questions and Answers Regarding the Scope of the Exception](https://www.fda.gov/regulatory-information/search-fda-guidance-documents/same-surgical-procedure-exception-under-21-cfr-127115b-questions-and-answers-regarding-scope) — US Food and Drug Administration (CBER) · evidence page: https://worldwiki.io/source/132
3. [A Study on Breast Augmentation Using Fat Grafting With Stromal Vascular Fraction (Shin DJ, Ann Plast Surg 2023;90(4):380-384)](https://pubmed.ncbi.nlm.nih.gov/36881737/) — Annals of Plastic Surgery · evidence page: https://worldwiki.io/source/27
4. [Cell-Assisted Lipotransfer: A Systematic Review of its Efficacy](https://pubmed.ncbi.nlm.nih.gov/37608190/) — Aesthetic Plastic Surgery (2024) · evidence page: https://worldwiki.io/source/23
5. [Comparison of the Efficacy and Safety of Cell-Assisted Lipotransfer and Platelet-Rich Plasma Assisted Lipotransfer](https://pubmed.ncbi.nlm.nih.gov/33845642/) — Cell Transplantation (2021) · evidence page: https://worldwiki.io/source/24
6. [Safety profile of autologous adipose-derived stromal vascular fraction in clinical use: an exhaustive literature review](https://pubmed.ncbi.nlm.nih.gov/41618435/) — Stem Cell Research & Therapy (2026) · evidence page: https://worldwiki.io/source/20
7. [Breast Augmentation by Fat Transplantation With Adipose-Derived Stem/Stromal Cells (Shin DJ, Aesthet Surg J Open Forum 2020)](https://pubmed.ncbi.nlm.nih.gov/33791627/) — Aesthetic Surgery Journal Open Forum · evidence page: https://worldwiki.io/source/28
8. [FDA Warns About Stem Cell Therapies](https://www.fda.gov/consumers/consumer-updates/fda-warns-about-stem-cell-therapies) — U.S. Food and Drug Administration · evidence page: https://worldwiki.io/source/2